![Maize and blue graphic of a vaccine.](/podcast/images/vaccines_web_670x350px.jpg)
Exploring the cost-effectiveness of RSV vaccines in older adults
Q&A with David Hutton
David Hutton, a professor of Health Management and Policy and Global Public Health, discusses the cost-effectiveness of RSV vaccination in older adults. Hutton and a group of University of Michigan researchers recently presented research on the topic during a meeting for the CDC's Advisory Committee on Immunization Practices (ACIP).